Several economic catalysts could push gold to $5,000 per ounce, but the timeline depends on when conditions shift.

BioMarin Pharmaceutical said on Monday it plans to divest its gene therapy, a product once expected to be a blockbuster treatment for a type of rare bleeding disorder.

In the Jewish People Policy Institute's "Annual Assessment of the Jewish People 2025," I discussed Zionism, antisemitism, and the situation of American Jews today.